![David D. W. Lee’s Day In The Life at ASCOBT24](https://oncodaily.com/pub/uploads/2024/08/davo-1-e1724418208408.png)
David D. W. Lee’s Day In The Life at ASCOBT24
American Society of Clinical Oncology (ASCO) shared a post on LinkedIn:
“Earlier this month ASCO Breakthrough brought together world-renowned clinicians and investigators who are putting cutting-edge research into practice.
Follow along with consultant clinical oncologist and past IDEA recipient Dr. David D. W. Lee for a Day In The Life at ASCOBT24 as he attends sessions, checks out posters, and makes connections.”
Proceed to the video attached to the post.
Source: ASCO/LinkedIn
David Lee Dai Wee is a Consultant Clinical Oncologist at the University of Malaya Medical Centre and a lecturer at the Faculty of Medicine, University of Malaya. He is the principal investigator for multiple international multicenter clinical trials, specializing in early-phase studies, thoracic cancers, and head and neck cancers.
Dr. Lee received the ASCO Leadership Development Program – Asia Pacific award in 2021-2022 and the ASCO International Development and Education Award (IDEA) in 2024, as well as the IASLC Academy Award in 2024.
The American Society of Clinical Oncology (ASCO) is a leading professional organization representing nearly 45,000 physicians and oncology specialists worldwide, dedicated to cancer care.
Founded in 1964 by Fred Ansfield, Harry Bisel, Herman Freckman, Arnoldus Goudsmit, Robert Talley, William Wilson, and Jane C. Wright, ASCO is committed to advancing cancer research, education, prevention, and high-quality patient care.